Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.5 Billion INR | -63.2% |
| 2022 | 16.67 Billion INR | -9.4% |
| 2021 | 18.4 Billion INR | 7.23% |
| 2020 | 17.16 Billion INR | 32.17% |
| 2019 | 12.98 Billion INR | -18.33% |
| 2018 | 15.89 Billion INR | 18.34% |
| 2017 | 13.43 Billion INR | -9.19% |
| 2016 | 14.79 Billion INR | 25.79% |
| 2015 | 11.76 Billion INR | 50.2% |
| 2014 | 7.83 Billion INR | -10.9% |
| 2013 | 8.78 Billion INR | -1.2% |
| 2012 | 8.89 Billion INR | 42.14% |
| 2011 | 6.25 Billion INR | -1.94% |
| 2010 | 6.38 Billion INR | 16.46% |
| 2009 | 5.47 Billion INR | 42.01% |
| 2008 | 3.85 Billion INR | -45.77% |
| 2007 | 7.11 Billion INR | 96.92% |
| 2006 | 3.61 Billion INR | 222.4% |
| 2005 | 1.12 Billion INR | -11.96% |
| 2004 | 1.27 Billion INR | 147.54% |
| 2003 | 514.23 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 4.7 Billion INR | 33.26% |
| 2023 Q4 | 3.53 Billion INR | 213.76% |
| 2023 Q1 | 4.76 Billion INR | 13.95% |
| 2023 Q2 | 3.22 Billion INR | -32.32% |
| 2023 Q3 | -3.1 Billion INR | -196.21% |
| 2023 FY | 6.13 Billion INR | -63.2% |
| 2022 FY | 16.67 Billion INR | -9.4% |
| 2022 Q4 | 4.18 Billion INR | -21.74% |
| 2022 Q1 | 2.84 Billion INR | 2.14% |
| 2022 Q2 | 5.63 Billion INR | 97.75% |
| 2022 Q3 | 5.34 Billion INR | -5.13% |
| 2021 Q4 | 2.78 Billion INR | -52.58% |
| 2021 Q1 | 4.6 Billion INR | -5.55% |
| 2021 Q2 | 4.53 Billion INR | -1.43% |
| 2021 FY | 18.4 Billion INR | 7.23% |
| 2021 Q3 | 5.88 Billion INR | 29.57% |
| 2020 Q4 | 4.87 Billion INR | 17.52% |
| 2020 Q3 | 4.14 Billion INR | -7.55% |
| 2020 Q1 | 3.64 Billion INR | 7.12% |
| 2020 FY | 17.16 Billion INR | 32.17% |
| 2020 Q2 | 4.48 Billion INR | 23.0% |
| 2019 Q1 | 2.51 Billion INR | 153.71% |
| 2019 Q3 | 3.34 Billion INR | -6.22% |
| 2019 Q2 | 3.56 Billion INR | 41.83% |
| 2019 FY | 12.98 Billion INR | -18.33% |
| 2019 Q4 | 3.4 Billion INR | 1.95% |
| 2018 Q4 | 990.04 Million INR | -70.98% |
| 2018 FY | 15.89 Billion INR | 18.34% |
| 2018 Q3 | 3.41 Billion INR | -1.61% |
| 2018 Q2 | 3.46 Billion INR | 29.62% |
| 2018 Q1 | 2.67 Billion INR | -12.79% |
| 2017 Q4 | 3.06 Billion INR | 72.47% |
| 2017 Q2 | 2.97 Billion INR | -36.88% |
| 2017 FY | 13.43 Billion INR | -9.19% |
| 2017 Q1 | 4.71 Billion INR | 71.23% |
| 2017 Q3 | 1.77 Billion INR | -40.22% |
| 2016 Q4 | 2.75 Billion INR | -56.21% |
| 2016 Q3 | 6.28 Billion INR | 97.11% |
| 2016 Q2 | 3.18 Billion INR | 0.04% |
| 2016 Q1 | 3.18 Billion INR | 46.46% |
| 2016 FY | 14.79 Billion INR | 25.79% |
| 2015 Q3 | 2.95 Billion INR | -7.47% |
| 2015 FY | 11.76 Billion INR | 50.2% |
| 2015 Q1 | 2.93 Billion INR | 50.1% |
| 2015 Q2 | 3.19 Billion INR | 8.85% |
| 2015 Q4 | 2.17 Billion INR | -26.27% |
| 2014 Q2 | 2.62 Billion INR | -3.53% |
| 2014 Q4 | 1.95 Billion INR | 1.09% |
| 2014 FY | 7.83 Billion INR | -10.9% |
| 2014 Q3 | 1.93 Billion INR | -26.29% |
| 2014 Q1 | 2.71 Billion INR | 198.13% |
| 2013 Q3 | 3.08 Billion INR | 15.0% |
| 2013 FY | 8.78 Billion INR | -1.2% |
| 2013 Q4 | 911.03 Million INR | -70.46% |
| 2013 Q1 | 2.15 Billion INR | 4.17% |
| 2013 Q2 | 2.68 Billion INR | 24.23% |
| 2012 FY | 8.89 Billion INR | 42.14% |
| 2012 Q4 | 2.07 Billion INR | -28.46% |
| 2012 Q2 | 2.45 Billion INR | 75.34% |
| 2012 Q1 | 1.39 Billion INR | 153.15% |
| 2012 Q3 | 2.89 Billion INR | 18.03% |
| 2011 Q3 | 904.7 Million INR | 0.0% |
| 2011 Q4 | 552.95 Million INR | -38.88% |
| 2011 FY | 6.25 Billion INR | -1.94% |
| 2010 FY | 6.38 Billion INR | 16.46% |
| 2009 FY | 5.47 Billion INR | 42.01% |
| 2008 FY | 3.85 Billion INR | -45.77% |
| 2007 FY | 7.11 Billion INR | 96.92% |
| 2006 FY | 3.61 Billion INR | 222.4% |
| 2005 FY | 1.12 Billion INR | -11.96% |
| 2004 FY | 1.27 Billion INR | 147.54% |
| 2003 FY | 514.23 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -341.17% |
| Ind-Swift Limited | 1.22 Billion INR | -430.389% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -1212.271% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 93.778% |
| Innova Captab Limited | 2.53 Billion INR | -156.665% |
| Divi's Laboratories Limited | 18.31 Billion INR | 64.487% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -45.34% |
| Morepen Laboratories Limited | 4.17 Billion INR | -55.789% |
| Mankind Pharma Limited | 40.86 Billion INR | 84.089% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -280.878% |
| Laurus Labs Limited | 3.94 Billion INR | -64.676% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -67.131% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 27.584% |
| Alembic Limited | 767.77 Million INR | -746.918% |
| Hikal Limited | 1.49 Billion INR | -335.175% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -12.926% |
| Neuland Laboratories Limited | 5.31 Billion INR | -22.269% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 13.78% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -31.569% |
| Themis Medicare Limited | 1.3 Billion INR | -398.991% |
| RPG Life Sciences Limited | 2.29 Billion INR | -183.662% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 85.675% |
| Lupin Limited | 27.75 Billion INR | 76.575% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -947.037% |
| Wockhardt Limited | 140 Million INR | -4544.557% |
| Vaishali Pharma Limited | 6.29 Million INR | -103210.772% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -107.869% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -2937.927% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -25.311% |
| FDC Limited | 3.03 Billion INR | -114.335% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 90.399% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -3025.393% |
| Eris Lifesciences Limited | 5.18 Billion INR | -25.487% |
| Venus Remedies Limited | 534.65 Million INR | -1116.191% |
| ZIM Laboratories Limited | 1.09 Billion INR | -492.141% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -428.219% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -1078.845% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 10.005% |
| Shilpa Medicare Limited | 3.76 Billion INR | -72.863% |
| Albert David Limited | 1.33 Billion INR | -387.268% |
| Ajanta Pharma Limited | 19.67 Billion INR | 66.955% |
| Hester Biosciences Limited | 364.77 Million INR | -1682.597% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -41.122% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 268.766% |
| Gufic Biosciences Limited | 2.89 Billion INR | -124.7% |
| Windlas Biotech Limited | 1.29 Billion INR | -400.611% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -133.395% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -229599.035% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -23581.186% |
| Granules India Limited | 6.52 Billion INR | 0.396% |
| Aarti Drugs Limited | 7.14 Billion INR | 9.041% |
| Bal Pharma Limited | 214.56 Million INR | -2930.438% |
| Alkem Laboratories Limited | 19.46 Billion INR | 66.589% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 93.766% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -241.095% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2635.989% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -31379.376% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -175.399% |
| Medico Remedies Limited | 277.11 Million INR | -2246.43% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -223.657% |
| Ipca Laboratories Limited | 29.59 Billion INR | 78.03% |
| Brooks Laboratories Limited | -72.25 Million INR | 9099.585% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2508.768% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 74.335% |
| NATCO Pharma Limited | 25.96 Billion INR | 74.954% |
| Suven Life Sciences Limited | -1.22 Billion INR | 630.451% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -24.428% |
| Indoco Remedies Limited | 1.52 Billion INR | -326.553% |
| Alpa Laboratories Limited | 61.51 Million INR | -10470.397% |
| Lasa Supergenerics Limited | -458 Million INR | 1519.718% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 258.015% |